COMMUNIQUÉS West-GlobeNewswire

Judge Denies Teva Pharmaceuticals’ Motion to Dismiss Corcept Therapeutics’ Allegations of Patent Infringement

24/10/2018 - 14:05

MENLO PARK, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic [...]

Inovio Pharmaceuticals to Report Third Quarter 2018 Financial Results on November 8, 2018

24/10/2018 - 14:00

PLYMOUTH MEETING, Pa., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it will host a conference call and live webcast to report its 2018 third quarter financial results [...]

Neos Therapeutics to Present New Data for ADHD Medication, Adzenys XR-ODT®, at the American Academy of Child & Adolescent Psychiatry Meeting

24/10/2018 - 14:00

DALLAS and FORT WORTH, Texas, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS) today announced that it will present new data for Adzenys XR-ODT (amphetamine) Extended-Release Orally- [...]

Samumed Phase 2b Trial in Knee Osteoarthritis Meets Primary Endpoints

24/10/2018 - 14:00

Pivotal phase 3 trials of SM04690 in knee osteoarthritis anticipated to begin early 2019 SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Samumed announced today top-line data from its phase 2b trial of SM04690 in knee [...]

Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)

24/10/2018 - 14:00

PRINCETON, N.J., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced an oral presentation regarding predictors of pregnancy in the Phase 3 SECURE [...]

CASMED to Report Third-Quarter 2018 Financial Results and Hold Conference Call on October 31

24/10/2018 - 14:00

BRANFORD, Conn., Oct. 24, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED ), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results [...]

VBI Vaccines to Present Initial Data for VBI-1901 in Recurrent Glioblastoma (GBM) Patients at the 2018 Annual Meeting of the Society for Neuro-Oncology (SNO)

24/10/2018 - 14:00

CAMBRIDGE, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]

TESARO and Actress Cobie Smulders Launch Not on My Watch, a National Movement to Empower the Ovarian Cancer Community

24/10/2018 - 14:00

Not on My Watch Aims to Shine a Light on the Importance of an Informed, Proactive Approach to Treatment WALTHAM, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused [...]

Principia Biopharma Appoints Dolca Thomas, M.D. as Chief Medical Officer

24/10/2018 - 14:00

- Succession designed to lead Principia through next phase of growth as a clinical-stage company - SOUTH SAN FRANCISCO, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a clinical-stage [...]

Dr. Anish Suri, Cue Biopharma’s CSO, to Present at Upcoming Precision: Lung Cancer Summit

24/10/2018 - 14:00

Overview and Update on the ImmunoSTAT™ Platform for Selective Targeting of Disease-Relevant T cells CAMBRIDGE, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma ™, Inc., (NASDAQ: CUE) an innovative immunotherapy [...]

Catalyst Biosciences Receives A Notice of Allowance from The Japan Patent Office Covering Modified Factor X Polypeptides

24/10/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications [...]

RedHill Biopharma Announces Final Patient Assessed in Confirmatory Phase III Study with TALICIA® for H. pylori Infection

24/10/2018 - 14:00

RedHill will host an Analyst and Investor Webcast on TALICIA ® for H. pylori infection on Tuesday, October 30, 2018, at 8:30 a.m. EDT Final patient assessed for primary endpoint, with top-line results expected before [...]

Surgery Partners, Inc. Announces Closing of New $180 Million Incremental Term Loan

24/10/2018 - 14:00

NASHVILLE, Tenn., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners”), a leading healthcare services company, today announced that Surgery Center Holdings, Inc., our wholly owned [...]

Immutep Announces Data Presentations at Upcoming Industry Conferences

24/10/2018 - 14:00

SYDNEY, Australia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

Correction: ViroGates releases third quarter 2018 results

24/10/2018 - 13:55

Correction: Financial statements now included Company announcement no. 7-2018 Birkerød, 24 October 2018 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for emergency departments in [...]

Inovalon Announces Third Quarter 2018 Earnings Conference Call

24/10/2018 - 13:55

BOWIE, Md., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that it will hold a [...]

KemPharm Presents Data from Intranasal and Intravenous Human Abuse Potential Trials of KP415 Prodrug at the American Academy of Child & Adolescent Psychiatry Meeting

24/10/2018 - 13:30

CORALVILLE, Iowa, Oct. 24, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced the presentation of [...]

Myriad to Announce Fiscal First-Quarter 2019 Financial Results on November 6, 2018

24/10/2018 - 13:05

SALT LAKE CITY, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will hold its fiscal first-quarter 2018 sales [...]

Helius Medical Technologies, Inc. Announces Second Partnership to Implement Clinical Experience Programs with PoNS™ Treatment in the United States

24/10/2018 - 13:05

NEWTOWN, Pa., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that its [...]